These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 15022004)
1. [Recommendations for secondary prevention after myocardial infarction]. Arntz HR Z Kardiol; 2004; 93 Suppl 1():I23-5. PubMed ID: 15022004 [TBL] [Abstract][Full Text] [Related]
2. [Sudden cardiac death (SCD) and guidelines for SCD]. Andresen D Z Kardiol; 2004; 93 Suppl 1():I4-6. PubMed ID: 15021998 [TBL] [Abstract][Full Text] [Related]
3. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction. Verboom CN; Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805 [TBL] [Abstract][Full Text] [Related]
4. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease. Richter WO Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328 [TBL] [Abstract][Full Text] [Related]
5. [Omega-3 fatty acids in cardiology. Latest developments]. von Schacky C MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786 [TBL] [Abstract][Full Text] [Related]
6. [Secondary prevention after myocardial infarction]. Czuriga I Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological aspects of secondary prevention post-MI]. Schrör K Z Kardiol; 2004; 93 Suppl 1():I1-3. PubMed ID: 15021997 [TBL] [Abstract][Full Text] [Related]
8. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Lamotte M; Annemans L; Kawalec P; Zoellners Y Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial. Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196 [TBL] [Abstract][Full Text] [Related]
10. Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction". Halcox JP Circulation; 2011 Jul; 124(1):e21; author reply e24-5. PubMed ID: 21730312 [No Abstract] [Full Text] [Related]
11. Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias. Pepe M; Recchia FA Cardiovasc Ther; 2010 Aug; 28(4):e1-4. PubMed ID: 20633018 [No Abstract] [Full Text] [Related]
12. Secondary prevention of coronary artery disease with omega-3 fatty acids. Jacobson TA Am J Cardiol; 2006 Aug; 98(4A):61i-70i. PubMed ID: 16919518 [TBL] [Abstract][Full Text] [Related]
13. [Highly concentrated omega-3-fatty acids. A new means in the secondary prevention]. MMW Fortschr Med; 2005 Oct; 147(43):60-1. PubMed ID: 16302426 [No Abstract] [Full Text] [Related]
14. Letter by Alter and Rupp regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction". Alter P; Rupp H Circulation; 2011 Jul; 124(1):e23; author reply e24-5. PubMed ID: 21730314 [No Abstract] [Full Text] [Related]
15. n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction. Khavandi A; Khavandi K; Greenstein A; Karsch K; Heagerty AM Heart; 2009 Apr; 95(7):540-1. PubMed ID: 19131442 [No Abstract] [Full Text] [Related]
16. Combination therapy with statins and omega-3 fatty acids. Nambi V; Ballantyne CM Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515 [TBL] [Abstract][Full Text] [Related]
17. Letter by Papageorgiou et al regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction". Papageorgiou N; Tousoulis D; Stefanadis C Circulation; 2011 Jul; 124(1):e22; author reply e24-5. PubMed ID: 21730313 [No Abstract] [Full Text] [Related]